| Melody E Terry, | |
|
5322 Us Highway 158, Advance, NC 27006-6907 | |
| (336) 940-5515 | |
| Not Available |
| Full Name | Melody E Terry |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 5322 Us Highway 158, Advance, North Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417602004 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 31037 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melody E Terry, 123 Piedmont Ave Apt B, Winston Salem, NC 27101-3638 Ph: (910) 206-4410 | Melody E Terry, 5322 Us Highway 158, Advance, NC 27006-6907 Ph: (336) 940-5515 |
News Archive
Molecules called microRNAs (miRNAs) that are measurable in urine have been identified by researchers at Mount Sinai as predictors of both heart and kidney health in children without disease.
Major progress has been made in the past 30 years in the knowledge and management of liver disease, yet approximately 29 million Europeans still suffer from a chronic liver condition. The European Association for the Study of the Liver (EASL) today unveiled its new publication The burden of liver disease in Europe: a review of available epidemiological data.
Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products among other core businesses, announces that its revolutionary ScopeGuide- technology can now be used within the United States.
States are seeing improvements in health care quality, but disparities for their minority and low- income residents persist, according to the 2010 State Snapshots, released today by the Agency for Healthcare Research and Quality.
In light of conflicting and inconclusive clinical data on the benefit of radiation therapy in cancer patients with the BRCA1 and BRCA2 mutation, a clinical review examined the current status of data regarding BRCA1 and BRCA2 deficiency and radiation therapy sensitivity and a potential strategy to intensify the effects of radiation therapy (RT) by poly(ADP-ribose) polymerase inhibitors (PARPi), the pharmacologic drugs under investigation as monotherapy for the treatment of breast cancer in patients with BRCA1 and BRCA2 mutations.
› Verified 8 days ago
Gregory Bodenheimer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5322 Us Highway 158, Advance, NC 27006 Phone: 336-940-5515 | |
Thomas Dustin Hayes, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5322 Us Highway 158, Advance, NC 27006 Phone: 336-940-5515 Fax: 336-940-4342 | |
Dr. Mark Howard Holshouser, PHD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1510 Nc Highway 801 N, Advance, NC 27006 Phone: 336-940-2193 | |
Dr. Dianna Choua Lee, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5322 Us Highway 158, Advance, NC 27006 Phone: 336-940-5515 | |
Karen Bencuya, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 260 Nc Highway 801 N, Advance, NC 27006 Phone: 336-998-6434 Fax: 336-998-6494 | |
Docia Okai, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5322 Us Highway 158, Advance, NC 27006 Phone: 336-940-5515 |